Skip to main content
Log in

Antineoplastics/folinic acid

Fatal febrile neutropenia: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Parisi A, et al. Clinicians' Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, "Real-Life", Case-Control Study. Clinical Colorectal Cancer 20: 318-325, No. 4, Dec 2021. Available from: URL: http://doi.org/10.1016/j.clcc.2021.07.003

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics/folinic acid. Reactions Weekly 1893, 49 (2022). https://doi.org/10.1007/s40278-022-09832-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-09832-x

Navigation